431 related articles for article (PubMed ID: 10385705)
1. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
[TBL] [Abstract][Full Text] [Related]
2. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
3. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
4. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
5. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors.
Morfis M; Tilakaratne N; Furness SG; Christopoulos G; Werry TD; Christopoulos A; Sexton PM
Endocrinology; 2008 Nov; 149(11):5423-31. PubMed ID: 18599553
[TBL] [Abstract][Full Text] [Related]
6. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagoshi Y; Eto T
Biochem Biophys Res Commun; 2003 Feb; 301(2):460-4. PubMed ID: 12565884
[TBL] [Abstract][Full Text] [Related]
7. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
8. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
[TBL] [Abstract][Full Text] [Related]
9. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.
Born W; Fischer JA; Muff R
Recept Channels; 2002; 8(3-4):201-9. PubMed ID: 12529937
[TBL] [Abstract][Full Text] [Related]
10. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
11. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin and related peptides: receptors and accessory proteins.
Muff R; Born W; Fischer JA
Peptides; 2001 Nov; 22(11):1765-72. PubMed ID: 11754962
[TBL] [Abstract][Full Text] [Related]
13. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
14. Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin.
Uezono Y; Nakamura E; Ueda Y; Shibuya I; Ueta Y; Yokoo H; Yanagita T; Toyohira Y; Kobayashi H; Yanagihara N; Wada A
Brain Res Mol Brain Res; 2001 Dec; 97(1):59-69. PubMed ID: 11744163
[TBL] [Abstract][Full Text] [Related]
15. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
16. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
17. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
18. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes.
Hay DL; Christopoulos G; Christopoulos A; Poyner DR; Sexton PM
Mol Pharmacol; 2005 May; 67(5):1655-65. PubMed ID: 15692146
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.
Steiner S; Muff R; Gujer R; Fischer JA; Born W
Biochemistry; 2002 Sep; 41(38):11398-404. PubMed ID: 12234182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
